
Central Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Central Asia: Medicaments Containing Insulin Market 2023
Medicaments Containing Insulin Imports
Imports in Central Asia
In 2021, overseas purchases of medicaments containing insulin but not antibiotics increased by 178% to X kg, rising for the second year in a row after two years of decline. In general, imports saw a significant expansion. The most prominent rate of growth was recorded in 2016 when imports increased by 867%. The volume of import peaked in 2021 and is expected to retain growth in the near future.
In value terms, medicaments containing insulin imports skyrocketed to $X in 2021. Overall, imports recorded a significant increase. The most prominent rate of growth was recorded in 2016 when imports increased by 3,411%. The level of import peaked in 2021 and is expected to retain growth in years to come.
Imports by Country
Turkmenistan prevails in imports structure, amounting to X kg, which was near 93% of total imports in 2021. The following importers - Kazakhstan (X kg) and Tajikistan (X kg) - together made up 6.9% of total imports.
Turkmenistan was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +317.9% from 2012 to 2021. Tajikistan (-4.5%) and Kazakhstan (-6.6%) illustrated a downward trend over the same period. While the share of Turkmenistan (+93 p.p.) and Tajikistan (+2.9 p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Kazakhstan (-96 p.p.) displayed negative dynamics.
In value terms, Turkmenistan ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Central Asia, comprising 96% of total imports. The second position in the ranking was taken by Kazakhstan ($X), with a 2.1% share of total imports.
From 2012 to 2021, the average annual growth rate of value in Turkmenistan totaled +272.4%. In the other countries, the average annual rates were as follows: Kazakhstan (-4.5% per year) and Tajikistan (+3.0% per year).
Import Prices by Country
In 2021, the import price in Central Asia amounted to $X per ton, with an increase of 4.4% against the previous year. In general, the import price continues to indicate a buoyant increase. The pace of growth was the most pronounced in 2016 when the import price increased by 263%. The level of import peaked at $X per ton in 2017; however, from 2018 to 2021, import prices stood at a somewhat lower figure.
There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Turkmenistan ($X per ton), while Kazakhstan ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Tajikistan (+7.8%), while the other leaders experienced mixed trends in the import price figures.
Base Year | Historical Period | Forecast Period | Units |
---|---|---|---|
2022 | 2012-2022 | 2023-2030 | US$, Tons |
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the medicaments containing insulin market in Central Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Making Data-Driven Decisions to Grow Your Business
A Quick Overview of Market Performance
Understanding the Current State of The Market and Its Prospects
Finding New Products to Diversify Your Business
Choosing the Best Countries to Establish Your Sustainable Supply Chain
Choosing the Best Countries to Boost Your Exports
The Latest Trends and Insights into The Industry
The Largest Importers on The Market and How They Succeed
The Largest Exporters on The Market and How They Succeed
The Largest Producers on The Market and Their Profiles
The Largest Markets And Their Profiles
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 22nd, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 8th, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, January 25th, 2022 @ 04:00 pm ET